Gene signatures associated with prognosis and chemotherapy resistance in glioblastoma treated with temozolomide

Overview of attention for article published in Frontiers in Genetics, December 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter: 2 X users

Readers on

mendeley: 8 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 5,863 followers.

A new groundbreaking study led by Dr. Tonia Carter identifies gene signatures linked to survival & temozolomide (TMZ) resistance in glioblastoma patients. An impressive stride in brain cancer research! Check it out: https://t.co/ySGttGimtK #Glioblastom

26 Dec 2023

Reply Repost Favourite

New Research: Gene signatures associated with prognosis and chemotherapy resistance in glioblastoma treated with temozolomide: Background: Glioblastoma (GBM) prognosis remains extremely poor despite standard treatment that includes temozolomide… https://t.

18 Dec 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.